Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON Share Price    (BICN)

Here is the latest stock price and chart of Biocon Ltd. For more details, see the Biocon Ltd company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Oct 11, 2019 (Close)
Price (Rs)247.50 Open (Rs) 242.40 High (Rs) 250.20 Low (Rs) 239.50
% Change3.04 Volume 327,240 Value (Rs) 80,170,117 52-Week H/L 341.50 / 211.30
Live NSE Quotes Oct 11, 2019 (Close)
Price (Rs)247.60 Open (Rs) 241.75 High (Rs) 250.40 Low (Rs) 239.25
% Change3.10 Volume 9,019,033 Value (Rs) 2,210,315,827 52-Week H/L 341.85 / 211.05
Valuation
EPS (Rs)* 13.36 P/E Ratio (x) 18.52 Market Cap (Rs m) 148,500.00 P/BV (x) 2.87
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors


Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

BIOCON Share Price Today:

BIOCON last traded price was up 3.0% to Rs 247.5 on the BSE. On the NSE, BIOCON last traded price was up 3.1% to Rs 247.6. The total volume of shares traded was 9.3 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.5%. And the benchmark S&P BSE SENSEX was at 38,127.1 (up 0.7%).

Over the last 30 days, the BIOCON share price is up 5.4%. And over the last one year, BIOCON share price is down 18.7%.





Today's Market

What Should You Do in Today's Volatile Markets?(Podcast)

The week gone by was pretty volatile for Dalal street and the global environment is as unpredictable as it can get.

Related Views On News

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Small Cap Stocks Could Triple in Less than 2 Years... Here's Why (Profit Hunter)

Sep 30, 2019

Historical data backs up my conviction.

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound? (Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Interest Rates Are Low. Buy Solid Dividend Stocks Instead (The 5 Minute Wrapup)

Sep 30, 2019

Select dividend stocks can be very rewarding.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

BIOCON - ADCOCK INGRAM COMPARISON

COMPARE BIOCON WITH

MARKET STATS